N/A
Completed N=109
Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV
Source: ClinicalTrials.gov NCT05020899 ↗Enrolled (actual)
109
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcomePrimary: Number of Participants With Biochemically Verified Smoking Cessation — 26; 10 Participants
Summary
The purpose of this two arm randomized clinical trial (RCT) is to test if a smoking cessation program called Quit for Life (QFL) which was developed by the investigators is effective for patients in China with HIV who smoke. This program is designed to suit the needs of people with HIV who smoke in China.
Eligible participants who provide consent will be randomized into either the QFL or the Control group.
The QFL group will receive a quit smoking program that lasts for 8 weeks with two parts-
1. 4 sessions with a trained counselor who will discuss the participants' smoking habits and strategies to help them quit.
2. Messages sent to the participants' cell phone using WeChat.
The Control group will not have sessions with a trained counselor or receive messages sent to their cell phone.
Both groups will be offered nicotine replacement therapy and a self-help guide with information about quitting smoking.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Biochemically Verified Smoking Cessation |
26; 10 | — |
| SECONDARY Number of Participants That Self Reported Smoking Cessation at 8 Weeks |
29; 37 | — |
| SECONDARY Number of Participants That Self Reported Smoking Cessation at 12 Weeks |
29; 40 | — |
| SECONDARY Change in Number of Cigarettes Smoked in the Previous 30 Days at 8 Weeks |
-169.29; -170.83 | — |
| SECONDARY Change in Number of Cigarettes Smoked in the Previous 30 Days at 12 Weeks |
-208.85; -191.84 | — |
| SECONDARY Number of Quit Attempts at 8 Weeks |
7; 13; 44; 36 | — |
| SECONDARY Number of Quit Attempts at 12 Weeks |
1; 10; 49; 38 | — |
| SECONDARY Adherence to Antiretroviral Treatments (ART) at 8 Weeks |
9.65; 9.10 | — |
| SECONDARY Adherence to Antiretroviral Treatments (ART) at 12 Weeks |
9.42; 9.02 | — |
| SECONDARY Quality of Life (QOL) in the Dimensions of Mobility, Self-care, Usual Activities, Pain/Discomfort, and Anxiety/Depression at 12 Weeks |
83.90; 79.75 | — |
Eligibility Criteria
Inclusion Criteria
- HIV seropositive (by being at the HIV clinic and receiving care)
- Receiving ART treatment from the clinic (by being at the HIV clinic and receiving care)
- Smokes ≥ 5 cigarettes per day
- Able to speak and read in Mandarin Chinese
- Self-reported anticipate to receive ART treatment from the clinic for at least 9 months
- Own a cell phone
- Be willing to set a quit date within 1 month after baseline assessment
Exclusion Criteria
- Self-reported using other smoking cessation program or medication
- Having a serious health problem that may make them unsuitable to stay in the study
Data sourced from ClinicalTrials.gov (NCT05020899). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.